Position in ZNTL
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$153,316
+$106,642 QoQ
Shares Held
65,520
+89.5% QoQ
Ownership
0.092%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZNTL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026FEDERATED HERMES, INC. holds $2,358,506,481 across 147 Biotechnology names. ZNTL ranks #90 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
687,816 | $227,577,679 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
254,946 | $196,981,475 | |
| 3 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,286,303 | $111,869,771 | |
| 4 | MRNA |
Moderna, Inc.
|
1,977,079 | $100,435,613 | |
| 5 | IDYA |
IDEAYA Biosciences, Inc.
|
2,987,107 | $99,530,405 | |
| 6 | INSM |
INSMED Inc
|
538,257 | $88,015,784 | |
| 7 | CNTA |
Centessa Pharmaceuticals plc
|
2,049,439 | $81,403,717 | |
| 8 | EYPT |
EyePoint, Inc.
|
5,669,589 | $73,081,000 |
All Filings in ZNTL
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $153,316 | 65,520 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $46,674 | 34,574 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $62,089 | 41,119 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $46,093 | 39,736 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $1,196,501 | 752,517 | Shares | Defined | 2025-05-08 | |
| 2024-12-31 | $1,496,764 | 493,982 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1,778,683 | 483,338 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,973,347 | 482,481 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $31,499,512 | 1,998,700 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $32,732,559 | 2,160,565 | Shares | Defined | 2024-01-31 | |
| 2023-09-30 | $39,070,721 | 1,947,693 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $56,934,381 | 2,018,234 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $25,576,365 | 1,486,998 | Shares | Defined | 2023-05-08 | |
| 2022-12-31 | $24,401,624 | 1,211,600 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $23,535,756 | 1,086,600 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $30,492,405 | 1,085,139 | Shares | Defined | 2022-09-16 | |
| 2022-03-31 | $43,876,048 | 950,933 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $81,929,918 | 974,660 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $85,458,002 | 1,282,383 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $67,812,231 | 1,274,666 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $60,934,269 | 1,404,339 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $40,465,155 | 779,075 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $25,467,961 | 779,075 | Shares | Defined | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||